A novel approach to treating osteoarthrosis as a chronic inflammatory disease
A large role in the pathogenesis of osteoarthrosis (OA) is assigned to proinflammatory cytokines, such as interleukin 1 (IL1) and tumor necrosis factor-α, which activate catabolic processes in the cartilaginous tissue and subchondral bone. Diacerein is a medication that is able to block IL1 receptor...
| 出版年: | Современная ревматология |
|---|---|
| 第一著者: | |
| フォーマット: | 論文 |
| 言語: | ロシア語 |
| 出版事項: |
IMA-PRESS LLC
2013-06-01
|
| 主題: | |
| オンライン･アクセス: | https://mrj.ima-press.net/mrj/article/view/488 |